Cara Therapeutics | CARA - الأصول





الأصول تغيير تاريخ
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Cara Therapeutics USD 25.82M 6.26M 2026-03
Cassava Sciences USD 100.06M 3.84M 2026-09
Chugai Pharma JPY 2.37T 75.59B 2026-09
Cipla INR 434.34B 9.38B 2026-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 138.36M 7.5M 2026-06
CSL USD 37.9B 1.5B 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
J&J USD 197.42B 3.64B 2026-09
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Pacira USD 34.68B 33.44B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
RedHill Biopharma USD 26.27M 929K 2026-06
Supernus Pharmaceuticals USD 1.4B 30.42M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12